为低中收入国家引入新母体免疫接种做准备
2018年5月比尔及梅琳达·盖茨基金会召集免疫规划与妇幼健康两大领域利益相关方,讨论在低中收入国家引入新母体疫苗的挑战与机遇,认为产前保健是合理平台,并确定政策协调、需求生成、实施研究和加强产前与围产期保健质量等优先事项。
要点
- 母体免疫可在婴儿出生后最初几个月提供保护,但需免疫规划与妇幼健康领域协作。
- 产前保健是合理平台,但资源受限地区产前保健提供者已超负荷且多数女性未完成推荐产前检查次数。
核心结论
- 在低中收入国家成功引入新母体疫苗需要免疫规划与妇幼健康两大领域协作,并需证明母体免疫的益处、确保国家和卫生系统做好准备。
研究设计与样本
- 比尔及梅琳达·盖茨基金会于2018年5月3-4日召集「母婴护理盟友」会议,免疫规划与妇幼健康领域利益相关方参加。
主要发现
- 与会者认为产前保健是引入母体免疫的合理平台,但资源受限地区产前保健提供者已超负荷,多数女性未接受推荐次数的产前检查。
- 实施母体免疫可能通过提供额外安全有效且女性重视的干预措施来提高产前保健利用率。
关键数值与推荐
- 与会者确定的优先事项包括:确保引入孕妇新疫苗政策的一致性并加强孕产妇健康干预;为现有、推荐和新母体疫苗生成需求;开展社会行为、卫生系统和实施研究以优化疫苗交付策略;加强产前和围产期护理质量。
临床怎么用
- 在低中收入国家引入母体免疫时应以产前保健为平台,并促进免疫规划与妇幼健康领域的跨领域协作。
局限性
- 本文为会议报告,未报告原始研究数据或定量分析结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
New strategies will be critical to reduce infant mortality and severe morbidity - there are still 5.2 million newborn deaths and stillbirths each year. The decline in newborn mortality has not kept pace with the reduction in under-five deaths and is slowest in low- and lower-middle-income countries (LMICs). Maternal immunization is a promising intervention to protect infants when they are most vulnerable - in utero and their first few months of life, before they can receive their own vaccines. Successfully introducing new vaccines for pregnant women in LMICs will require collaboration between two fields - (1) immunization and (2) maternal, newborn and child health - that use different service delivery approaches, operate under different policy and funding paradigms, and are not always integrated. In May 2018, stakeholders from these distinct communities convened to identify challenges and opportunities associated with delivering new maternal immunizations. Participants agreed that antenatal care is a logical platform. However, in many resource-constrained settings, antenatal care providers are already overburdened, and most women do not receive the recommended number of antenatal visits. Implementing maternal immunization could help increase antenatal care attendance by offering an additional safe and effective intervention that women value. Substantial effort is needed to demonstrate the benefits of maternal immunization to decision-makers and providers, and to ensure that countries and health systems are ready for introduction. To that end, participants identified the following priorities: assure coherence of policies for introducing new vaccines for pregnant women and strengthen maternal health interventions; generate demand for existing, recommended, and new maternal vaccines; conduct socio-behavioral, health systems and implementation research to shape optimal vaccine delivery strategies; and strengthen antenatal and perinatal care quality. To achieve these aims, collaboration across fields will be essential. Given that new maternal vaccines are advancing in clinical development, time is of the essence.
引用
- Sobanjo-Ter Meulen A, Liljestrand J, Lawn JE, et al. Preparing to introduce new maternal immunizations in low- and lower-middle-income countries: A report from the Bill & Melinda Gates Foundation convening "Allies in Maternal and Newborn Care"; May 3-4, 2018. Vaccine. 2020. PMID: 32418791. doi:10.1016/j.vaccine.2020.04.075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。